Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Dilution has begun
View:
Post by lv_426 on Jul 16, 2020 5:48am

Dilution has begun

https://www.stockwatch.com/News/Item?bid=Z-C%3aRP-2934530&symbol=RP®ion=C At least not bankrupt...yet
Comment by Ingiboy on Jul 16, 2020 8:38pm
Bad news & good news. Dilution but working capital. We also got a bit of an update, vague as it is. The Dermal Injector is obviously at the top of the list for to do items for this fresh money injection.
Comment by BellEnd on Jul 16, 2020 8:47pm
This post has been removed in accordance with Community Policy
Comment by lv_426 on Jul 17, 2020 6:50pm
But how about when thhat monry funs out?
Comment by BellEnd on Jul 17, 2020 9:14pm
This post has been removed in accordance with Community Policy
Comment by Ingiboy on Jul 17, 2020 10:58pm
I think this first Tranche of shares has produced enough working capital to get the Dermal Injector to CE Mark approval.  It will be interesting to see how many more shares will be sold before they close this offering in 3 weeks.  The question is:  will there be an update before this Private Placement is close.
Comment by Ingiboy on Jul 23, 2020 4:10pm
I guess the answer is no.  We wait.  They obviously are sitting on this update until the audit is completed and the Private Placement is closed.  You would think that there would be some speculators banking on good news coming because of people buying into this Private Placement but that has not been the case.  
Comment by Year3000 on Jul 24, 2020 2:46am
So the audit completes at the end of the month, when is the private placement supposed to close? 
Comment by Ingiboy on Jul 24, 2020 10:31am
This is from the July 15th NR:  We anticipate closing on a larger tranche of funding shortly with investors who have already expressed commitments to participate. Such funding will ensure we are able to submit our application for marketing approval of our dermal injector, launch sales of the injector and consumables, and trigger the first milestone payment from our partner in greater China ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities